Specialty Pharmacy

MRIs show brain changes related to multiple sclerosis before symptom onset.

A hepatitis C virus diagnosis may curb drug use among those in treatment.

The mechanisms of BRCA mutations are still largely unknown.

Top news of the day from across the healthcare landscape.

Calcipotriene and betamethasone dipropionate treats mild to moderate plaque psoriasis in adult patients.

Physician and pharmacist collaboration is key within the complex pain management prescribing landscape.

A derivative of a natural compound could stop HIV replication and prevent a viral rebound.

PPARγ agonists may improve outcomes for patients with acute myeloid leukemia.

The presence of certain bacteria could result in worsening of multiple sclerosis.

Two supplemental biologics license applications granted to golimumab to treat adults with psoriatic arthritis and adults with active ankylosing spondylitis.

Dabrafenib (Tafinlar) plus trametinib (Mekinist) improved relapse-free survival for patients with melanoma with a BRAF V600 mutation.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, talks about using medical marijuana for the treatment of specialty conditions.

Fifteen researchers receive more than $22 million for rare disease clinical trials.

Developing a vaccine that launches immune attacks against cancer proves to be difficult.

Top news of the day from across the healthcare landscape.

Singrix is a recombinant vaccine indicated for the prevention of herpes zoster in older adults.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the impact of orphan drugs across the specialty landscape.

Many children with HIV who are diagnosed with asthma may actually have chronic obstructive lung disease.

A look at last week's top stories in the world of pharmacy.

Top news of the day from across the healthcare landscape.

Top news of the week from Specialty Pharmacy Times.

The FDA a stop to Celgene’s REVOLVE trial and extension trial for GED-0301 (mongersen), an oral compound currently not approved for any uses.

Early detection is crucial for breast cancer survival.

The Partnership for Accelerating Cancer Therapies seeks to standardize biomarkers for cancer immunotherapy drugs.

Moderately effective vaccine could boost efforts to cure HIV.

Allergy medication may cause remyelination in humans with multiple sclerosis.

Top news from across the healthcare landscape.

FDA says ‘yes’ to axicabtagene ciloleucel (Yescarta), a gene therapy for lymphoma.